CYRAMZA, combined with other medications, is used for the treatment of patients with advanced gastric cancer or GEJ, metastatic non-small cell lung cancer (NSCLC), and metastatic colorectal cancer (mCRC).
Capecitabine is a nucleoside metabolic inhibitor with antineoplastic activity indicated for adjuvant colon cancer, metastatic colorectal cancer, and metastatic breast cancer.
Find information about Herceptin® (trastuzumab), a targeted therapy for HER2 Positive Metastatic Breast Cancer and HER2 Positive Gastric Cancer.
Learn more about OPDIVO® (nivolumab). Prescribed medication to treat certain types of cancers. Read about its indications, clinical data and efficacy.
Learn about Eleview™, a submucosal injection agent designed to lift polyps and keep them lifted during gastrointestinal endoscopic resection procedures.
For US Healthcare Professionals. View Indications, Usage & Full Prescribing Information
Learn about LENVIMA (lenvatinib) clinical trial, dosing information, & patient reimbursement information. See Important Safety Information.
Oncozene Microspheres are precisely calibrated to enhance treatment options
ONIVYDE® (irinotecan liposome injection) in combination for patients with metastatic pancreatic cancer previously treated with gemcitabine. See Important Safety Information, including Boxed Warning.
Ontruzant is a HER2/neu receptor antagonist indicated for: The treatment of HER2-overexpressing breast cancer. The treatment of HER2-overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma.
Gemzar. GEMZAR (gemcitabine for injection), for intravenous use. Initial U.S. Approval: 1996 ..... http://www.osha.gov/SLTC/hazardousdrugs/index.html. 2.7.
Lipiodol is an oil-based radio-opaque contrast agent indicated for: selective hepatic intra-arterial use for imaging tumors in adults with known hepatocellular carcinoma (HCC); hysterosalpingography in adults; lymphography in adult and pediatric patients ...
Learn more about ABRAXANE®, including dosing, efficacy, and safety information. This site is intended for US healthcare professionals only.
Learn about Avastin® (bevacizumab) for FDA approved indications. Recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer (rOC) Avastin, in combination with paclitaxel, pegylated liposomal doxorubicin, or topotecan, is indicated for the treatment of patients with platinum-resistant recurrent epithelial
Secretin, Human Secretin, secretin stimulation test, SMRCP, ERCP, Gastrinoma, EUS, EPFT, MRCP, pancreas, Zollinger-Ellison Syndrome, pancreatic cancer, ChiRhoStim, chronic pancreatitis, acute pancreatitis, pancreatic exocrine dysfunction, facilitating and cannulate ERCP, pancreas divisum, gastrinoma
Info for healthcare professionals on SUTENT® (sunitinib malate) for treatment of adv RCC, imatinib-resistant/intolerant GIST, and adv pNET. See risks & benefits.
Xeloda is indicated as a single agent for adjuvant treatment in patients with Dukes’ C colon cancer
First-line treatment for EGFR mutation-positive metastatic NSCLC with exon 19 deletions or exon 21 (L858R) substitution mutations
Healthcare Professional site for NEXAVAR® (sorafenib). Learn more about whether NEXAVAR is appropriate for your patients.
NEXPLANON should not be used in women who have known or suspected pregnancy; current or past history of thrombosis or thromboembolic disorders; liver tumors, benign or malignant, or active liver disease; undiagnosed abnormal genital bleeding; known or suspected breast cancer, personal history of breast cancer, ...